Improving Patient Acceptability and Adherence in Psoriasis Treatment

Main Article Content

Alyssa Curcio
Wake Forest School of Medicine Department of Dermatology

Christina Kontzias
Wake Forest School of Medicine Department of Dermatology

Steven R Feldman
Wake Forest School of Medicine Department of Dermatology

Keywords

acceptability, psoriasis, adherence, treatment

Abstract

N/A

References

1. Savary J, Ortonne JP, Aractingi S. The right dose in the right place: an overview of current prescription, instruction and
application modalities for topical psoriasis treatments. J Eur Acad Dermatol Venereol. 2005 Nov;19 Suppl 3:14-7. doi:
10.1111/j.1468 3083.2005.01333.x. PMID: 16274407.

2. Feldman SR, Horn EJ, Balkrishnan R, Basra MK, Finlay AY, McCoy D, Menter A, van de Kerkhof PC; International
Psoriasis Council. Psoriasis: improving adherence to topical therapy. J Am Acad Dermatol. 2008 Dec;59(6):1009-16. doi:
10.1016/j.jaad.2008.08.028. Epub 2008 Oct 2. PMID: 18835062.

3. Florek AG, Wang CJ, Armstrong AW. Treatment preferences and treatment satisfaction among psoriasis patients: a
systematic review. Arch Dermatol Res. 2018 May;310(4):271-319. doi: 10.1007/s00403-018-1808-x. Epub 2018 Feb 13.
PMID:29442137.

Article Sidebar

Poster PDF
Published
Nov 16, 2022
DOI https://doi.org/10.25251/skin.6.supp.59

Article Details

How to Cite
[1]
Curcio, A., Kontzias, C. and Feldman, S.R. 2022. Improving Patient Acceptability and Adherence in Psoriasis Treatment. SKIN The Journal of Cutaneous Medicine. 6, 6 (Nov. 2022), s59. DOI:https://doi.org/10.25251/skin.6.supp.59.
Issue
Vol. 6 No. 6 (2022): November Issue & Poster Presentations from FC22 Dermatology Conference®
Section
Poster Presentations from FC22 Dermatology Conference®: Psoriasis
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Most read articles by the same author(s)